Healthcare Malaysia Market 9.5% CAGR Growth, Trends, Forecasts, Research and Markets 2022

Summary
The industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Malaysia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/7400-countryfocus-healthcare-regulatory-and-reimbursement-landscape-malaysia

In 2015, Malaysia’s population stood at 31 million. The past five years have seen steady population growth, which is expected to continue in the future due to a high birth rate, low mortality rate and increased life expectancy. Government initiatives such as Entry Point Projects (EPPs), specifically EPP3, and National Key Economic Areas (NKEAs) to increase investment in the pharmaceutical industry have so far have been successful. The country’s pharmaceutical market was estimated at $2.3 billion in 2015 and is projected to reach approximately $3.6 billion by 2020 at a CAGR of 9.5%. The medical device market was worth an estimated $1.7 billion in 2015, but is growing and currently constitutes approximately 25% of the healthcare expenditure.

These positive trends can primarily be attributed to -
- An increasing elderly population
- Government initiatives to improve healthcare facilities
- An increase in medical tourism

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Malaysia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pharmaniaga Berhad, Chemical Company of Malaysia Berhad (CCM), Yung Shin Pharmaceutical, Hovid and Kotra Pharma
- Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Malaysian healthcare market

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Malaysia’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Malaysia’s healthcare market

Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 16
2.1 GlobalData Report Guidance 16
3 Overview of the Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 20
3.1.3 Supply Channels 21
3.1.4 Market Segments 22
3.1.5 Major Disease Areas 23
3.1.6 Major Companies 25
3.2 Medical Device Market 54
3.3 Market Drivers and Barriers 57
3.3.1 Drivers 57
3.3.2 Barriers 58
4 Market Access 60
4.1 Reimbursement and Payer Landscape 60
4.1.1 Overview of Healthcare System 60
4.1.2 Reimbursement Process 61
4.1.3 Overview of Insurance Providers 62
4.1.4 Patient Share in Healthcare Spending 65
4.1.5 Price Trends in the Healthcare Sector 66
5 Country Analysis 91
5.1 Political Environment 91
5.1.1 Political Structure 91
5.1.2 Analysis of the Current Political Environment 93
5.1.3 Healthcare Policy Initiatives 94
5.2 Economic Landscape 96
6 Opportunities and Challenges 151
6.1 Opportunities 151
6.2 Challenges 151
7 Appendix 153
7.1 Abbreviations 153
7.2 Bibliography 157
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/7400-countryfocus-healthcare-regulatory-and-reimbursement-landscape-malaysia

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.